MedPath

海南锦麟医药科技有限公司

Ownership
-
Established
2021-12-30
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

溃疡胶囊

Approval Number
国药准字Z20013181
Approval Date
Sep 4, 2020
NMPA

Trimetazidine Hydrochloride Capsules

Product Name
盐酸曲美他嗪胶囊
Approval Number
国药准字H20100145
Approval Date
Sep 4, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.